Stockreport

ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call

ProSomnus, Inc.  (OSA) 
PDF PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, anno [Read more]